脓毒症患者CD4+T细胞中GLS表达降低作为与铜死亡相关的预后指标
本研究利用脓毒症患者外周血样本检测铜死亡相关基因(CRGs)表达,并按CRG表达水平对患者分型,发现不同亚型间预后与基因表达模式存在显著差异。通过加权基因共表达网络分析(WGCNA)识别出3个可能影响脓毒症患者预后的关键CRGs,并用免疫细胞浸润分析、scRNA-seq及免疫印迹、流式细胞术、免疫荧光和CFSE分析验证关键CRG在特定免疫细胞中的表达及调控机制。在Jurkat细胞中验证GLS表达降低伴随O-GlcNAc水平下降,四硫代钼酸盐螯合铜不能逆转GLS与O-GlcNAc的降低。作者认为所识别的铜死亡相关分子标志物可能作为脓毒症患者的诊断指标,FDX1与LIAS的改变可通过铜螯合逆转,而铜与GLS改变的相关性需进一步研究。
要点
- 按铜死亡相关基因表达水平对脓毒症患者分型,不同亚型间预后与基因表达模式存在显著差异。
- WGCNA识别出3个可能影响脓毒症患者预后的关键铜死亡相关基因。
- Jurkat细胞中GLS表达降低伴随O-GlcNAc水平下降,四硫代钼酸盐螯合铜不能逆转该降低。
- 过度螯合铜对线粒体功能、细胞活力、细胞增殖及宿主免疫状态有害。
- FDX1与LIAS的改变可通过铜螯合逆转,铜与GLS改变的相关性需进一步研究。
适用人群与场景
- 脓毒症患者,外周血样本用于铜死亡相关基因表达检测与分型
研究设计与关键结果
- 研究类型:基于脓毒症患者外周血样本的分子标志物研究,采用WGCNA构建共表达网络识别关键预后CRGs,并行免疫细胞浸润分析及scRNA-seq验证关键CRG在特定免疫细胞中的表达。
- 按CRG表达水平对脓毒症患者分型后,不同亚型间预后与基因表达模式存在显著差异。
- 识别出3个可能影响脓毒症患者预后的关键CRGs。
- Jurkat细胞中验证GLS表达降低,伴随O-GlcNAc水平下降;四硫代钼酸盐螯合铜不能逆转GLS与O-GlcNAc水平的降低。
- 过度螯合铜对线粒体功能、细胞活力、细胞增殖及宿主免疫状态有害。
- FDX1与LIAS的改变可通过铜螯合逆转;铜与GLS改变的相关性需进一步研究。
证据类型、等级与局限
- 证据类型:分子标志物研究(外周血样本基因表达分析、WGCNA、免疫细胞浸润分析、scRNA-seq及Jurkat细胞功能实验)。
- 局限:作者指出铜与GLS改变的相关性需进一步研究。
对床旁实践的改变
- 作者认为所识别的铜死亡相关分子标志物可能作为脓毒症患者的诊断指标。
- 作者报告过度螯合铜对线粒体功能、细胞活力、细胞增殖及宿主免疫状态有害。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Objectives: Sepsis is defined as a life-threatening disease associated with a dysfunctional host immune response. Stratified identification of critically ill patients might significantly improve the survival rate. The present study sought to probe molecular markers associated with cuproptosis in septic patients to aid in stratification and improve prognosis. Methods: We studied expression of cuproptosis-related genes (CRGs) using peripheral blood samples from septic patients. Further classification was made by examining levels of expression of these potential CRGs in patients. Coexpression networks were constructed using the Weighted Gene Coexpression Network Analysis (WGCNA) method to identify crucial prognostic CRGs. Additionally, we utilized immune cell infiltration analysis to further examine the immune status of septic patients with different subtypes and its association with the CRGs. scRNA-seq data were also analyzed to verify expression of key CRGs among specific immune cells. Finally, immunoblotting, flow cytometry, immunofluorescence, and CFSE analysis were used to investigate possible regulatory mechanisms. Results: We classified septic patients based on CRG expression levels and found significant differences in prognosis and gene expression patterns. Three key CRGs that may influence the prognosis of septic patients were identified. A decrease in GLS expression was subsequently verified in Jurkat cells, accompanied by a reduction in O-GlcNAc levels, and chelation of copper by tetrathiomolybdate could not rescue the reduction in GLS and O-GLcNAc levels. Moreover, immoderate chelation of copper was detrimental to mitochondrial function, cell viability, and cell proliferation, as well as the immune status of the host. Conclusion: We have identified novel molecular markers associated with cuproptosis, which could potentially function as diagnostic indicators for septic patients. The reversible nature of the observed alterations in FDX1 and LIAS was demonstrated through copper chelation, whereas the correlation between copper and the observed changes in GLS requires further investigation.
参考来源
- Yang J, Chen N, Zhao P, et al. DIMINISHED EXPRESSION OF GLS IN CD4 + T CELLS SERVES AS A PROGNOSTIC INDICATOR ASSOCIATED WITH CUPROPTOSIS IN SEPTIC PATIENTS. Shock. 2024. PMID: 38662604. doi:10.1097/SHK.0000000000002370
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。